伤口世界
  • 首页
  • 病情图文
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
      • 动脉性溃疡
      • 静脉性溃疡
      • 放射性溃疡
    • 烧伤
    • 创伤
    • 少见伤口
    • 祛疤止痒
    • 皮肤病
  • 医师讲座
  • 名医介绍
    专业服务
    • 糖尿病足
    • 压疮
    • 造口
    • 溃疡
    • 烧伤
    蔡道章院长

    Custom Mod Mega1

    主任医师、教授、博导,南方医科大学第三附属医院(广东省骨科医院)院长

    • 中德骨科伤口管理学校校长
    • 广东省骨科研究院运动医学研究所所长
    • 广东省内运动医学专业唯一的博士研究生导师
    • 美国哈弗大学医学院骨科访问学者
    • 专业特长处于省内领先、国内或国际先进水平以上
    • 2018年获得“国之名医卓越建树”荣誉称号
    • 2017年被评为全国卫生计生系统先进工作者、广东省医学领军人才
    • 中国医师协会运动医师分会副会长
    • STCOT中国部运动医学分会副主任委员
    • 广东省医学会关节外科分会主任委员
    • 广东省医学会运动医学会分会名誉主任委员
    • 独立承担过国家“863”课题,主持过10余项省、部级科研项目
    • 多份专业杂志编委
  • 文献精选
    伤口分类
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
    • 烧伤
    • 更多关于伤口信息
    最新文献
    • 中国肝细胞癌经动脉介入治疗 临床实践指南(2026版) 2026-09-28 00:00

      中国医师协会介入医师分会临床诊疗指南专委会

      通信作者:滕皋军,东南大学附属中大医院介入与血管外科,南京 210009,Email:该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

      【摘要】 经动脉介入治疗(TAI)应用于肝细胞癌(HCC),主要包括经动脉化疗栓塞(TACE)、经动脉栓塞(TAE)、肝动脉灌注化疗(HAIC)和选择性内放射治疗(SIRT)。TACE是治疗不可切除HCC的首选方法,中国医师协会介入医师分会(CCI)分别于2018、2021和2023年制订并更新了《中国肝细胞癌经动脉化疗栓塞(TACE)治疗临床实践指南》,为规范我国 TACE 临床实践发挥了重要作用。近年来,HAIC、SIRT在国内的应用日趋广泛并不断规范。随着TAI技术的进步、治疗理念的更新以及近年来高级别循证医学证据的出现,CCI在既往指南内容基础上,整合TACE、HAIC、SIRT内容并更新颁布《中国肝细胞癌经动脉介入治疗临床实践指南(2026版)》。本指南以最新循证医学证据为基础,结合我国临床实践,涵盖了TAI应用于HCC治疗的新进展,从临床诊断标准与分期、患者适应证与禁忌证、操作流程及要求、围手术期处理、常见并发症及处理、随访及疗效评价、联合治疗、质量控制及热点和展望等方面阐述,旨在进一步规范TAI在HCC治疗中的应用。

      【关键词】 癌,肝细胞; 介入放射学,治疗性; 实践指南; 经动脉介入治疗

      实践指南注册:国际实践指南注册与透明化平台(PREPARE‑2025CN046)

      Chinese clinical practice guidelines for transarterial interventions of hepatocellular carcinoma (2026 edition)

      Clinical Guidelines Committee of Chinese College of Interventionalists

      Corresponding author: Teng Gaojun, Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Southeast University, Nanjing 210009, China, Email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

      【Abstract】 Transarterial interventions (TAI) for hepatocellular carcinoma (HCC) include transarterial chemoembolization (TACE), transarterial embolization (TAE), hepatic arterial infusion chemotherapy (HAIC), and selective internal radiation therapy (SIRT). TACE remains the first‑line treatment for unresectable HCC. Chinese College of Interventionalists (CCI) previously issued and updated the Chinese Clinical Practice Guidelines of TACE for HCC in 2018, 2021, and 2023, which have played a pivotal role in standardizing TACE procedures in China. In recent years, the application of HAIC and SIRT has become increasingly widespread and standardized in China. With the continuous advancement of TAI techniques, the evolution of therapeutic concepts, and the emergence of high‑level evidence, CCI has comprehensively revised and expanded its previous guidelines. The updated Chinese clinical practice guidelines for transarterial interventions of hepatocellular carcinoma (2026 edition) now formally incorporates TACE, HAIC, and SIRT as standard treatment modalities. With the aims to further standardize the use of TAI in the management of HCC, this guideline is developed based on the most current evidence‑based medical research, integrates China‑specific clinical practices, and incorporates the latest advancements in TAI for HCC. It elaborates on clinical diagnostic criteria and staging, patient indications and contraindications, operational procedures and requirements, perioperative management, common complications management, follow‑up and efficacy evaluation, combination therapy, quality control, as well as hot topics and prospects.

      【Key words】 Carcinoma, hepatocellular; Interventional radiology, therapeutic; Practice guideline; Transarterial interventions

      Practice guideline registration: Practice Guideline Registration for Transparency (PREPARE‑2025CN046)

    • Use of Bleach Baths for Atopic Dermatitis: An Indian Perspective 2026-09-27 00:00

      Nidhi Sharma, Sandipan Dhar, Abhishek De, Kiran Godse, D S Krupa Shankar, Vijay Zawar, Mukesh Girdhar, Bela Shah

      Abstract

      Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder affecting 15–20% of children and 1–10% of adults. Staphylococcus aureus (S. aureus) infection is the most frequent complication of AD and is involved in the worsening of the disease. Systemic and topical antibiotics are used in the treatment for AD but there are concerns over increasing resistance. Bleach (sodium hypochlorite, NaOCl) baths are an inexpensive, widely accessible, alternative antibiotic treatment that may not worsen antibiotic resistance. Bleach baths are used as adjunctive treatment in AD patients to treat superinfections, although their mechanism of action is not well understood. Balancing safety concerns with efficacious treatment should be important especially for AD where the majority of patients are in pediatrics age groups. Studies available in PubMed databases were included in this review. Most suggested bleach bath improves clinical symptoms of AD and restores surface microbiome by eradicating bacteria, most notably S. aureus. Some studies have noted that this antimicrobial effect has reduced the need for topical corticosteroids. In addition, bleach seems to have strong anti-inflammatory and antipruritic effects. Overall, bleach baths seem to be safe on human skin, without disrupting the epidermal barrier function. The review concluded, although there are some advantages of use of bleach baths, more studies to investigate long-term efficacy and safety of bleach baths are required before fixing its role in the treatment of AD especially in the context of the Indian scenario.

      Key Words: Atopic dermatitis, bleach baths, sodium hypochlorite

  • 互动快递
  • 首页
  • 病情图文
    • 糖尿病足
    • 压疮
    • 感染伤口
    • 造口
    • 溃疡
      • 动脉性溃疡
      • 静脉性溃疡
      • 放射性溃疡
    • 烧伤
    • 创伤
    • 少见伤口
    • 祛疤止痒
    • 皮肤病
  • 医师讲座
  • 名医介绍
    • 专业服务
      • 糖尿病足
      • 压疮
      • 造口
      • 溃疡
      • 烧伤
    • 蔡道章院长
  • 文献精选
    • 伤口分类
      • 糖尿病足
      • 压疮
      • 感染伤口
      • 造口
      • 溃疡
      • 烧伤
      • 更多关于伤口信息
    • 最新文献
  • 互动快递
  • 当前位置: 
  • 首页
  • بلوق K2
  • Listing
  • Listing 1 column

文献精选

Understanding the causes of skincare product pilling

Understanding the causes of skincare product pilling

伤口世界,
2025-09-05 00:00
发布于 文献精选
1505 Views
0 Comment

Facial Skincare Routine Adherence in the General Population

Facial Skincare Routine Adherence in the General Population

伤口世界,
2025-09-04 00:00
发布于 文献精选
1122 Views
0 Comment

Molecular farming expression of recombinant fusion proteins applied to skincare strategies

Molecular farming expression of recombinant fusion proteins applied to skincare strategies

伤口世界,
2025-09-03 00:00
发布于 文献精选
1165 Views
0 Comment

Artificial Intelligence in the Evolution of Customized Skincare Regimens

Artificial Intelligence in the Evolution of Customized Skincare Regimens

伤口世界,
2025-09-02 00:00
发布于 文献精选
1408 Views
0 Comment

  • 首页
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 末页
第63页 共499页

Categories

  • 病情图文
  • 文献精选
  • 名医介绍
  • K2 Content
  • 中国肝细胞癌经动脉介入治疗 临床实践指南(2026版) 2026-09-28 00:00

    中国医师协会介入医师分会临床诊疗指南专委会

    通信作者:滕皋军,东南大学附属中大医院介入与血管外科,南京 210009,Email:该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

    【摘要】 经动脉介入治疗(TAI)应用于肝细胞癌(HCC),主要包括经动脉化疗栓塞(TACE)、经动脉栓塞(TAE)、肝动脉灌注化疗(HAIC)和选择性内放射治疗(SIRT)。TACE是治疗不可切除HCC的首选方法,中国医师协会介入医师分会(CCI)分别于2018、2021和2023年制订并更新了《中国肝细胞癌经动脉化疗栓塞(TACE)治疗临床实践指南》,为规范我国 TACE 临床实践发挥了重要作用。近年来,HAIC、SIRT在国内的应用日趋广泛并不断规范。随着TAI技术的进步、治疗理念的更新以及近年来高级别循证医学证据的出现,CCI在既往指南内容基础上,整合TACE、HAIC、SIRT内容并更新颁布《中国肝细胞癌经动脉介入治疗临床实践指南(2026版)》。本指南以最新循证医学证据为基础,结合我国临床实践,涵盖了TAI应用于HCC治疗的新进展,从临床诊断标准与分期、患者适应证与禁忌证、操作流程及要求、围手术期处理、常见并发症及处理、随访及疗效评价、联合治疗、质量控制及热点和展望等方面阐述,旨在进一步规范TAI在HCC治疗中的应用。

    【关键词】 癌,肝细胞; 介入放射学,治疗性; 实践指南; 经动脉介入治疗

    实践指南注册:国际实践指南注册与透明化平台(PREPARE‑2025CN046)

    Chinese clinical practice guidelines for transarterial interventions of hepatocellular carcinoma (2026 edition)

    Clinical Guidelines Committee of Chinese College of Interventionalists

    Corresponding author: Teng Gaojun, Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Southeast University, Nanjing 210009, China, Email: 该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。

    【Abstract】 Transarterial interventions (TAI) for hepatocellular carcinoma (HCC) include transarterial chemoembolization (TACE), transarterial embolization (TAE), hepatic arterial infusion chemotherapy (HAIC), and selective internal radiation therapy (SIRT). TACE remains the first‑line treatment for unresectable HCC. Chinese College of Interventionalists (CCI) previously issued and updated the Chinese Clinical Practice Guidelines of TACE for HCC in 2018, 2021, and 2023, which have played a pivotal role in standardizing TACE procedures in China. In recent years, the application of HAIC and SIRT has become increasingly widespread and standardized in China. With the continuous advancement of TAI techniques, the evolution of therapeutic concepts, and the emergence of high‑level evidence, CCI has comprehensively revised and expanded its previous guidelines. The updated Chinese clinical practice guidelines for transarterial interventions of hepatocellular carcinoma (2026 edition) now formally incorporates TACE, HAIC, and SIRT as standard treatment modalities. With the aims to further standardize the use of TAI in the management of HCC, this guideline is developed based on the most current evidence‑based medical research, integrates China‑specific clinical practices, and incorporates the latest advancements in TAI for HCC. It elaborates on clinical diagnostic criteria and staging, patient indications and contraindications, operational procedures and requirements, perioperative management, common complications management, follow‑up and efficacy evaluation, combination therapy, quality control, as well as hot topics and prospects.

    【Key words】 Carcinoma, hepatocellular; Interventional radiology, therapeutic; Practice guideline; Transarterial interventions

    Practice guideline registration: Practice Guideline Registration for Transparency (PREPARE‑2025CN046)

  • Use of Bleach Baths for Atopic Dermatitis: An Indian Perspective 2026-09-27 00:00

    Nidhi Sharma, Sandipan Dhar, Abhishek De, Kiran Godse, D S Krupa Shankar, Vijay Zawar, Mukesh Girdhar, Bela Shah

    Abstract

    Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder affecting 15–20% of children and 1–10% of adults. Staphylococcus aureus (S. aureus) infection is the most frequent complication of AD and is involved in the worsening of the disease. Systemic and topical antibiotics are used in the treatment for AD but there are concerns over increasing resistance. Bleach (sodium hypochlorite, NaOCl) baths are an inexpensive, widely accessible, alternative antibiotic treatment that may not worsen antibiotic resistance. Bleach baths are used as adjunctive treatment in AD patients to treat superinfections, although their mechanism of action is not well understood. Balancing safety concerns with efficacious treatment should be important especially for AD where the majority of patients are in pediatrics age groups. Studies available in PubMed databases were included in this review. Most suggested bleach bath improves clinical symptoms of AD and restores surface microbiome by eradicating bacteria, most notably S. aureus. Some studies have noted that this antimicrobial effect has reduced the need for topical corticosteroids. In addition, bleach seems to have strong anti-inflammatory and antipruritic effects. Overall, bleach baths seem to be safe on human skin, without disrupting the epidermal barrier function. The review concluded, although there are some advantages of use of bleach baths, more studies to investigate long-term efficacy and safety of bleach baths are required before fixing its role in the treatment of AD especially in the context of the Indian scenario.

    Key Words: Atopic dermatitis, bleach baths, sodium hypochlorite

  • Hypochlorous Acid: Applications in Dermatology 2026-09-24 00:00

    Nicole Natarelli, BA 1 , Yvonne Nong, MS 2,3,4 , Jessica Maloh, ND 2,3 , Raja Sivamani, MD, MS, AP 2,3,5,6 a

    1 Morsani College of Medicine, University of South Florida, Tampa, Florida, 2 Pacific Skin Institute, Sacramento, CA, 3 Zen Dermatology, Sacramento,

    CA, 4 Michigan State University College of Human Medicine, Flint, Michigan, 5 Department of Dermatology, University of California-Davis, Sacramento,

    CA , 6 College of Medicine, California Northstate University, Elk Grove, CA

    Keywords: hypochlorous acid, integrative dermatology, wound healing, scar management, infection, atopic dermatitis, pruritus

    Relevance

    Hypochlorous acid (HClO) is a weak acid and powerful oxidant traditionally used as an active ingredient in various sanitizers and disinfectants. HClO is produced endogenously from activated leukocytes, and it was first exogenously synthesized in 1834, later to be used medicinally as a wound disinfectant during World War I and II.

    Objective

    In this review, we aim to review the literature assessing the efficacy and safety of dermatologic uses of topical hypochlorous acid.

    Methods

    A PubMed search for articles with the following keywords was performed: “hypochlorous acid” AND “dermatology” OR “dermis” OR “dermal.” Forty-one reports were included in the efficacy and safety analysis.

    Results

    Hypochlorous acid exhibits antimicrobial properties and has been demonstrated to promote re-epithelialization in wound healing with low cytotoxicity to keratinocytes and fibroblasts. Recent work has highlighted its anti-inflammatory properties via modulation of the NF-kβ signaling pathway and downregulation of inflammatory cytokines; reports have discussed its application for the management of various inflammatory skin conditions including atopic dermatitis and psoriasis.

    Conclusion

    Dermatologic application of hypochlorous acid includes infection prevention, wound care and scar management, inflammatory modulation, treatment in atopic dermatitis and pruritus. Emerging research has discussed potential applications in acne vulgaris, seborrheic dermatitis, and tumor suppression.

Popular Tags

  • 糖尿病足
  • 造口
  • 溃疡
  • 动脉性溃疡
  • 静脉性溃疡
  • 放射性溃疡
  • 烧伤
  • 创伤
  • 祛疤止痒
  • 皮肤病

伤口世界平台生态圈,以“关爱人间所有伤口患者”为愿景,连接、整合和拓展线上和线下的管理慢性伤口的资源,倡导远程、就近和居家管理慢性伤口,解决伤口专家的碎片化时间的价值创造、诊疗经验的裂变复制、和患者的就近、居家和低成本管理慢性伤口的问题。

 

消息订阅

关注伤口世界动态,了解专业领域最新科技
Copyright © 2026 中诺医疗. All Rights Reserved
粤ICP备20066836号

学术会议

2019广东省医疗行业协会伤口管理分会年会

扫一扫了解详情:

 

  • 2019年6月15日 中国广州
  • 主办单位:广东省医疗行业协会伤口管理分会

伤口世界提示

任何关于疾病的建议都不能替代执业医师的面对面诊断。所有门诊时间仅供参考,最终以医院当日公布为准。

网友、医生言论仅代表其个人观点,不代表本站同意其说法,请谨慎参阅,本站不承担由此引起的法律责任。